Document Detail


Papillomavirus prophylactic vaccines: established successes, new approaches.
MedLine Citation:
PMID:  19906917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vaccines against the human papillomaviruses (HPVs) most frequently associated with cancer of the cervix are now available. These prophylactic vaccines, based on virus-like particles (VLPs), are extremely effective, providing protection from infection in almost 100% of cases. However, the vaccines present some limitations: they are effective primarily against the HPV type present in the vaccine, are expensive to produce, and need a cold chain. Vaccines based on the minor capsid protein L2 have been very successful in animal models and have been shown to provide a good level of protection against different papillomavirus types. The potential of L2-based vaccines to protect against many types of HPVs is discussed.
Authors:
M Saveria Campo; Richard B S Roden
Related Documents :
16404997 - Molecular characterization and phylogenetic analysis of newcastle disease virus isolate...
18501287 - Accidental introduction of viruses into companion animals by commercial vaccines.
14778927 - Immunological reactions of the coxsackie viruses. iii. cross-protection tests in infant...
7738147 - Differentiation between glycoprotein iii gene-deleted vaccine and wild-type strains of ...
2073347 - Successful treatment of a 95 per cent body surface area burn.
18400977 - Efficient testing of large pools of mycobacterium tuberculosis rd1 peptides and identif...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2009-11-11
Journal Detail:
Title:  Journal of virology     Volume:  84     ISSN:  1098-5514     ISO Abbreviation:  J. Virol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-12     Completed Date:  2010-02-18     Revised Date:  2013-05-31    
Medline Journal Info:
Nlm Unique ID:  0113724     Medline TA:  J Virol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1214-20     Citation Subset:  IM    
Affiliation:
Division of Pathological Sciences, Institute of Comparative Medicine, Garscube Campus, University of Glasgow, Glasgow G61 1QH, United Kingdom. s.campo@vet.gla.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alphapapillomavirus / chemistry,  genetics,  physiology,  ultrastructure
Animals
Humans
Microscopy, Electron
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / administration & dosage*
Grant Support
ID/Acronym/Agency:
P50 CA098252/CA/NCI NIH HHS; R01 CA118790/CA/NCI NIH HHS; R01 CA133749/CA/NCI NIH HHS; //Cancer Research UK
Chemical
Reg. No./Substance:
0/Papillomavirus Vaccines; 0/human papillomavirus vaccine L1, type 6,11,16,18
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescenc...
Next Document:  Chimeric feline coronaviruses encoding type II spike protein on type I genetic background display ac...